Transcend Medical plans to file a premarket approval application with the FDA later this year for the CyPass micro-stent, the company announced in a press release.The COMPASS trial, a prospective, multicenter, randomized controlled trial including 500 …
DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today the appointment of John Strobel as Vice President of Sales. Mr. Strobel will be responsible for Presbia’s international sales expansion of the Presbia Flexivue Microlens™. “John’s extensive experience in the ophthalmology industry as well as his demonstrated tra
NEW YORK–(BUSINESS WIRE)–Ophthotech Corporation announced that it will release its first quarter 2015 financial results after close of market on Monday, May 11, 2015.
Shire and the Foundation Fighting Blindness announced an agreement to focus on research regarding a treatment for autosomal dominant retinitis pigmentosa, according to a Shire press release.The Foundation Fighting Blindness and its research partners wi…
TAMPA, Fla.–(BUSINESS WIRE)–Retina Associates of Tampa pilot study suggests that single Ranibizumab injection with peripheral laser therapy can treat DME associated with peripheral retina nonperfusion.
DENVER — Eye banks may successfully prepare and transport fully peeled corneal tissue for Descemet’s membrane endothelial keratoplasty, according to a presentation here.In a poster presented at the Association for Research in Vision and Ophthalmology annual meeting, Hussain Elhalis, MD, and colleagues evaluated fully peeling vs. partially peeling the corneal tissue in 27 donor corneas to determine endothelial cell density (ECD).